Literature DB >> 20427484

Susceptibility to diet-induced hepatic steatosis and glucocorticoid resistance in FK506-binding protein 52-deficient mice.

Manya Warrier1, Terry D Hinds, Kelly J Ledford, Harrison A Cash, Payal R Patel, Thomas A Bowman, Lance A Stechschulte, Weidong Yong, Weinian Shou, Sonia M Najjar, Edwin R Sanchez.   

Abstract

Although FK506-binding protein 52 (FKBP52) is an established positive regulator of glucocorticoid receptor (GR) activity, an in vivo role for FKBP52 in glucocorticoid control of metabolism has not been reported. To address this question, FKBP52(+/-) mice were placed on a high-fat (HF) diet known to induce obesity, hepatic steatosis, and insulin resistance. Tissue profiling of wild-type mice showed high levels of FKBP52 in the liver but little to no expression in muscle or adipose tissue, predicting a restricted pattern of FKBP52 effects on metabolism. In response to HF, FKBP52(+/-) mice demonstrated a susceptibility to hyperglycemia and hyperinsulinemia that correlated with reduced insulin clearance and reduced expression of hepatic CEACAM1 (carcinoembryonic antigen-related cell adhesion molecule 1), a mediator of clearance. Livers of HF-fed mutant mice had high lipid content and elevated expression of lipogenic genes (peroxisome proliferator-activated receptor gamma, fatty acid synthase, and sterol regulatory element-binding protein 1c) and inflammatory markers (TNFalpha). Interestingly, mutant mice under HF showed elevated serum corticosterone, but their steatotic livers had reduced expression of gluconeogenic genes (phosphoenolpyruvate carboxy kinase, glucose 6 phosphatase, and pyruvate dehydrogenase kinase 4), whereas muscle and adipose expressed normal to elevated levels of glucocorticoid markers. These data suggest a state of glucocorticoid resistance arising from liver-specific loss of GR activity. Consistent with this hypothesis, reduced expression of gluconeogenic genes and CEACAM1 was observed in dexamethasone-treated FKBP52-deficient mouse embryonic fibroblast cells. We propose a model in which FKBP52 loss reduces GR control of gluconeogenesis, predisposing the liver to steatosis under HF-diet conditions attributable to a shunting of metabolism from glucose production to lipogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20427484      PMCID: PMC2903936          DOI: 10.1210/en.2009-1158

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  69 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Essential role for Co-chaperone Fkbp52 but not Fkbp51 in androgen receptor-mediated signaling and physiology.

Authors:  Weidong Yong; Zuocheng Yang; Sumudra Periyasamy; Hanying Chen; Selcul Yucel; Wei Li; Leanne Y Lin; Irene M Wolf; Martin J Cohn; Laurence S Baskin; Edwin R Sa Nchez; Weinian Shou
Journal:  J Biol Chem       Date:  2006-12-01       Impact factor: 5.157

Review 3.  FKBP52.

Authors:  Todd H Davies; Edwin R Sánchez
Journal:  Int J Biochem Cell Biol       Date:  2005-01       Impact factor: 5.085

4.  Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor.

Authors:  Hung-Yun Lin; I-Chen Yu; Ruey-Shen Wang; Yei-Tsung Chen; Ning-Chun Liu; Saleh Altuwaijri; Cheng-Lung Hsu; Wen-Lung Ma; Jenny Jokinen; Janet D Sparks; Shuyuan Yeh; Chawnshang Chang
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

5.  PPARalpha governs glycerol metabolism.

Authors:  David Patsouris; Stéphane Mandard; Peter J Voshol; Pascal Escher; Nguan Soon Tan; Louis M Havekes; Wolfgang Koenig; Winfried März; Sherrie Tafuri; Walter Wahli; Michael Müller; Sander Kersten
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

6.  Effect of acute physiological hyperinsulinemia on gene expression in human skeletal muscle in vivo.

Authors:  Dawn K Coletta; Bogdan Balas; Alberto O Chavez; Muhammad Baig; Muhammad Abdul-Ghani; Sangeeta R Kashyap; Franco Folli; Devjit Tripathy; Lawrence J Mandarino; John E Cornell; Ralph A Defronzo; Christopher P Jenkinson
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-03-11       Impact factor: 4.310

Review 7.  Role of endogenous androgen against insulin resistance and athero- sclerosis in men with type 2 diabetes.

Authors:  Michiaki Fukui; Yoshihiro Kitagawa; Hiroyuki Ose; Goji Hasegawa; Toshikazu Yoshikawa; Naoto Nakamura
Journal:  Curr Diabetes Rev       Date:  2007-02

Review 8.  Glucocorticoids, metabolism and metabolic diseases.

Authors:  Alexandros Vegiopoulos; Stephan Herzig
Journal:  Mol Cell Endocrinol       Date:  2007-06-02       Impact factor: 4.102

9.  GILZ, a new target for the transcription factor FoxO3, protects T lymphocytes from interleukin-2 withdrawal-induced apoptosis.

Authors:  Marie-Liesse Asselin-Labat; Muriel David; Armelle Biola-Vidamment; Damiana Lecoeuche; Maria-Christina Zennaro; Jacques Bertoglio; Marc Pallardy
Journal:  Blood       Date:  2004-03-18       Impact factor: 22.113

10.  Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease.

Authors:  Varman T Samuel; Zhen-Xiang Liu; Xianqin Qu; Benjamin D Elder; Stefan Bilz; Douglas Befroy; Anthony J Romanelli; Gerald I Shulman
Journal:  J Biol Chem       Date:  2004-05-27       Impact factor: 5.157

View more
  23 in total

Review 1.  Regulation of steroid hormone receptor function by the 52-kDa FK506-binding protein (FKBP52).

Authors:  Jeffrey C Sivils; Cheryl L Storer; Mario D Galigniana; Marc B Cox
Journal:  Curr Opin Pharmacol       Date:  2011-04-19       Impact factor: 5.547

2.  The 90-kDa heat-shock protein (Hsp90)-binding immunophilin FKBP51 is a mitochondrial protein that translocates to the nucleus to protect cells against oxidative stress.

Authors:  Luciana I Gallo; Mariana Lagadari; Graciela Piwien-Pilipuk; Mario D Galigniana
Journal:  J Biol Chem       Date:  2011-07-05       Impact factor: 5.157

Review 3.  FKBP51 and FKBP52 in signaling and disease.

Authors:  Cheryl L Storer; Chad A Dickey; Mario D Galigniana; Theo Rein; Marc B Cox
Journal:  Trends Endocrinol Metab       Date:  2011-08-31       Impact factor: 12.015

Review 4.  FKBP51-a selective modulator of glucocorticoid and androgen sensitivity.

Authors:  Lance A Stechschulte; Edwin R Sanchez
Journal:  Curr Opin Pharmacol       Date:  2011-05-11       Impact factor: 5.547

5.  Mice with hyperbilirubinemia due to Gilbert's syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPARα.

Authors:  Terry D Hinds; Peter A Hosick; Shujuan Chen; Robert H Tukey; Michael W Hankins; Andrea Nestor-Kalinoski; David E Stec
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-01-17       Impact factor: 4.310

Review 6.  The glucocorticoid receptor: cause of or cure for obesity?

Authors:  Kezia John; Joseph S Marino; Edwin R Sanchez; Terry D Hinds
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-12-29       Impact factor: 4.310

Review 7.  Chaperoning steroidal physiology: lessons from mouse genetic models of Hsp90 and its cochaperones.

Authors:  Edwin R Sanchez
Journal:  Biochim Biophys Acta       Date:  2011-12-04

8.  FKBP51 reciprocally regulates GRα and PPARγ activation via the Akt-p38 pathway.

Authors:  Lance A Stechschulte; Terry D Hinds; Simona S Ghanem; Weinian Shou; Sonia M Najjar; Edwin R Sanchez
Journal:  Mol Endocrinol       Date:  2014-06-16

Review 9.  Steroid Receptor-Associated Immunophilins: A Gateway to Steroid Signalling.

Authors:  Thomas Ratajczak; Carmel Cluning; Bryan K Ward
Journal:  Clin Biochem Rev       Date:  2015-05

10.  The helix 1-3 loop in the glucocorticoid receptor LBD is a regulatory element for FKBP cochaperones.

Authors:  Carmel Cluning; Bryan K Ward; Sarah L Rea; Ajanthy Arulpragasam; Peter J Fuller; Thomas Ratajczak
Journal:  Mol Endocrinol       Date:  2013-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.